Biomarker Testing Advocacy: Biomarker testing is an important part of precision medicine; however, many commercial health plans and state Medicaid programs do not provide adequate coverage for these services. But recent legislative wins may mean things are changing. We speak to two healthcare advocates to discuss recent policy changes as they relate to biomarker testing.  

Precision Medicine Disparities: Authors of an ACCC/LUNGevity Foundation study that identifies key areas of clinician need related to biomarker testing in non-small cell lung cancer discuss the need for more knowledge about precision medicine guidelines, the practical applications of guideline-concordant testing, the importance of patient-clinician discussion and education, and access to appropriate clinical trials. 

Genetic Testing & Telehealth: Uncover common barriers to genetic counseling and biomarker testing for patients with cancer and learn how providers can help expand the use of testing and counseling delivered via telehealth to educate, inform, and improve patient care. 

What You Need to Know about Liquid Biopsy: Learn about the current clinical applications of liquid biopsies, their associated reimbursement issues, and what can be done to implement these tests at cancer programs and practices. 

Telehealth & Genetics During COVID-19: Explore how genetic healthcare services have adapted to virtual delivery and what challenges there are to the widespread use of telehealth medicine after the pandemic is over. 

The Promise of Bispecific Antibodies: The redirection of T cells against tumors holds significant promise for the treatment of cancer. Learn about promising breakthroughs, the challenges to widespread use, and what cancer teams need to know about the future of cancer treatment. 

Immunotherapy (IO) & Dermatology: Immune-related adverse events most often present on the skin for patients undergoing immunotherapy. Learn about dermatology’s role in the cancer care continuum and how cancer teams can better integrate dermatology into the IO care process. 

IO Clinical Trials During COVID-19: Learn how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to conduct clinical trials safely and effectively during the pandemic. 

Immunotherapy & Mental Health: Learn how cancer care providers can better integrate mental health awareness into the immunotherapy care continuum and the mental health implications of treatment with cancer IO. 

Survivorship Care After Immunotherapy: Learn about the transition from immunotherapy to post-treatment survivorship, how immunotherapy differs from chemotherapy after treatment, and why coordination and communication among providers, patients, and caregivers is essential.